Sectm1a Facilitates Protection against Inflammation-Induced Organ Damage through Promoting TRM Self-Renewal

Xingjiang Mu,Hongkuan Fan,Peng Wang,Yutian Li,Karen Domenico,Qianqian Li,Xiaohong Wang,Kobina Essandoh,Jing Chen,Tianqing Peng,Guo-Chang Fan

DOI: https://doi.org/10.1016/j.ymthe.2020.12.001

IF: 12.91

2021-03-01

Molecular Therapy

Abstract:<p>Tissue-resident macrophages (TRMs) are sentinel cells for maintaining tissue homeostasis and organ function. In this study, we discovered that LPS administration dramatically reduced TRM populations and suppressed their self-renewal capacities in multiple organs. Using loss- and gain-of-function approaches, we define Sectm1a as a novel regulator of TRM self-renewal. Specifically, at the earlier stage of endotoxemia, Sectm1a deficiency exaggerated acute inflammation-caused reduction of TRM numbers in multi-organs by suppressing their proliferation, associated with more infiltrations of inflammatory monocytes/neutrophils and more serious organ damages. By contrast, administration of recombinant Sectm1a enhanced TRM populations and improved animal survival upon endotoxin challenge. Mechanistically, we identified that Sectm1a-induced upregulation in the self-renewal capacity of TRM is dependent on GITR-activated T-helper cell expansion and cytokine production. Meanwhile, we found that TRMs may play an important role in protecting local vascular integrity during endotoxemia. Our study demonstrates that Sectm1a contributes to stabling TRM populations through maintaining their self-renewal capacities, which benefits the host immune response to acute inflammation. Therefore, Sectm1a may serve as a new therapeutic agent for the treatment of inflammatory diseases.</p>

genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **The effect of Sectm1a on the self - renewal ability of tissue - resident macrophages (TRMs) in inflammation - induced organ damage and its underlying mechanisms**.

Specifically, the study found that lipopolysaccharide (LPS) administration significantly reduced the number of TRMs in multiple organs and inhibited their self - renewal ability. Through loss - of - function and gain - of - function experiments, the researchers determined that Sectm1a is a new regulator of TRM self - renewal. The study showed that in the early stage of endotoxemia, Sectm1a deficiency exacerbates the reduction in the number of TRMs caused by acute inflammation, leading to more inflammatory monocyte/neutrophil infiltration and more severe organ damage. Conversely, administration of recombinant Sectm1a enhanced the number of TRMs and improved the survival rate of animals after endotoxin challenge.

### Summary of main problems:
1. **How does Sectm1a affect the self - renewal ability of TRMs?**
- Studies have shown that Sectm1a can maintain the self - renewal ability of TRMs by promoting the expansion of Th2 effector cells.

2. **What is the mechanism of action of Sectm1a in the inflammatory response?**
- Sectm1a upregulates the self - renewal ability of TRMs by activating the expansion of T - helper cells and cytokine production through GITR.

3. **Can Sectm1a be used as a new target for the treatment of inflammatory diseases?**
- The research results indicate that increasing the level of Sectm1a may become a new method for the treatment of inflammatory diseases.

### Key findings:
- Sectm1a deficiency aggravates LPS - induced multi - organ damage.
- Recombinant Sectm1a significantly alleviates the LPS - induced reduction in TRMs and the harmful infiltration of inflammatory monocytes/neutrophils, improving the survival rate of mice.
- The expression of Sectm1a in the spleen, lungs, and heart is significantly downregulated, especially after LPS treatment.
- Sectm1a deficiency leads to a further reduction in the number of TRMs in the spleen and lungs, accompanied by more infiltration of inflammatory monocytes and neutrophils.
- Sectm1a deficiency also exacerbates the reduction in cardiac - resident macrophages (CRMs).

### Potential mechanisms:
- Sectm1a enhances the self - renewal ability of TRMs by promoting the expansion of Th2 effector cells.
- Sectm1a binds to GITR, activates T - helper cell expansion and cytokine production, thereby promoting the self - renewal of TRMs.

These findings reveal the important role of Sectm1a in maintaining the number and function of TRMs, providing a theoretical basis for the development of new anti - inflammatory treatment methods.